Urinary protein profiles in a rat model for diabetic complications

Molecular and Cellular Proteomics

Volumn 8, Issue 9, 2009, Pages 2145-2158

  Schlatzer, Daniela M ^a   Dazard, Jean Eudes ^a   Dharsee, Moyez ^c   Ewing, Rob M ^a,c   Ilchenko, Serguei ^a   Stewart, Ian ^c   Christ, George ^b   Chance, Mark R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Infochromics   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GLUCOSE; INSULIN; PROCOLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; EARLY DIAGNOSIS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STREPTOZOCIN DIABETES; UNITED STATES; URINALYSIS;

AMINO ACID SEQUENCE; ANIMALS; COLLAGEN; DIABETES COMPLICATIONS; DISEASE MODELS, ANIMAL; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDES; PRINCIPAL COMPONENT ANALYSIS; PROTEOME; QUALITY CONTROL; RATS; RATS, INBRED F344; REPRODUCIBILITY OF RESULTS; STAINING AND LABELING;

ANIMALIA; RATTUS;

EID: 71149090202     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M800558-MCP200     Document Type: Article

References (78)

1. United States Renal Data System SAF: www.usrdsorg/odr/xrender-homeasp (2004) Accessed February 2008
2. Association, A. D. (2002) Diabetic nephropathy. Diabetes Care 25, S85-S88
3. Maahs, D. M., and Rewers, M. (2006) Editorial: Mortality and renal disease in type 1 diabetes mellitus-Progress made, more to be done. J. Clin. Endocrinol. Metab. 91, 3757-3759
4. Andersen, A. R., Christiansen, J. S., Andersen, J. K., Kreiner, S., and Deckert, T. (1983) Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25, 496-501
5. Remuzzi, G., Macia, M., and Ruggenenti, P. (2006) Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. J. Am. Soc. Nephrol. 17, Suppl. 2, S90-S97
6. Hughes, D. B., and Britton, M. L. (2005) Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus. Pharmacotherapy 25, 1602-1620 (Pubitemid 41566919)
7. Peters, T., Jr. (2006) How should we measure the albumin in urine? Clin. Chem. 52, 555-556
8. Perkins, B. A., and Krolewski, A. S. (2005) Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress. Curr. Diab. Rep. 5, 455-463
9. Kelly, D. J. (2000) Experimental diabetic nephropathy: Is it relevant to the human disease. Nephrology 5, 177-185
10. Cooper, M. E., Allen, T. J., O'brien, R. C., Papazoglou, D., Clarke, B. E., Jerums, G., and Doyle, A. E. (1990) Nephropathy in a model combining genetic hypertension with experimental diabetes: Enalapril versus hydralazine and metoprolol therapy. Diabetes 39, 1575-1579
11. O'Brien, R. C., Cooper, M. E., Jerums, G., and Doyle, A. E. (1993) The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy. Diabetes 42, 604-609 (Pubitemid 23097194)
12. Sassy-Prigent, C., Heudes, D., Jouquey, S., Auberval, D., Belair, M. F., Michel, O., Hamon, G., Bariety, J., and Bruneval, P. (1995) Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition. Lab. Invest. 73, 64-71
13. Rossini, A. A., Like, A. A., Chick, W. L., Appel, M. C., and Cahill, G. F., Jr. (1977) Studies of streptozotocin-induced insulitis and diabetes. Proc. Natl. Acad. Sci. U. S. A. 74, 2485-2489
14. Allen, T. J., Cooper, M. E., O'Brien, R. C., Bach, L. A., Jackson, B., and Jerums, G. (1990) Glomerular filtration rate in streptozocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy. Diabetes 39, 1182-1190
15. Gilbert, R. E., Cox, A., Dziadek, M., Cooper, M. E., and Jerums, G. (1995) Extracellular matrix and its interactions in the diabetic kidney: a molecular biological approach. J. Diabetes Complications 9, 252-254
16. Hirose, K., Osterby, R., Nozawa, M., and Gundersen, H. J. (1982) Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int. 21, 689-695
17. McLennan, S. V., Fisher, E. J., Yue, D. K., and Turtle, J. R. (1994) High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy. Diabetes 43, 1041-1045
18. Christ, G. J., Hsieh, Y., Zhao, W., Schenk, G., Venkateswarlu, K., Wang, H. Z., Tar, M. T., and Melman, A. (2006) Effects of streptozotocin-induced diabetes on bladder and erectile (dys)function in the same rat in vivo. BJU Int. 97, 1076-1082
19. Yohannes, E., Chang, J., Christ, G. J., Davies, K. P., and Chance, M. R. (2008) Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction. Mol. Cell. Proteomics 7, 1270-1285
20. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V., and Mann, M. (2006) The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 7, R80 (Pubitemid 44614864)
21. Pang, J. X., Ginanni, N., Dongre, A. R., Hefta, S. A., and Opitek, G. J. (2002) Biomarker discovery in urine by proteomics. J. Proteome Res. 1, 161-169
22. Sun, W., Li, F., Wu, S., Wang, X., Zheng, D., Wang, J., and Gao, Y. (2005) Human urine proteome analysis by three separation approaches. Proteomics 5, 4994-5001 (Pubitemid 43016918)
23. Zerefos, P. G., Vougas, K., Dimitraki, P., Kossida, S., Petrolekas, A., Stravodimos, K., Giannopoulos, A., Fountoulakis, M., and Vlahou, A. (2006) Characterization of the human urine proteome by preparative electrophoresis in combination with 2-DE. Proteomics 6, 4346-4355
24. Hortin, G. L., Jortani, S. A., Ritchie, J. C., Jr., Valdes, R., Jr., and Chan, D. W. (2006) Proteomics: a new diagnostic frontier. Clin. Chem. 52, 1218-1222
25. Pisitkun, T., Johnstone, R., and Knepper, M. A. (2006) Discovery of urinary biomarkers. Mol. Cell. Proteomics 5, 1760-1771
26. Thongboonkerd, V. (2008) Searching for novel biomarkers and new therapeutic targets of diabetic nephropathy using proteomics approaches. Contrib. Nephrol. 160, 37-52
27. Dihazi, H., Müller, G. A., Lindner, S., Meyer, M., Asif, A. R., Oellerich, M., and Strutz, F. (2007) Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin. Chem. 53, 1636-1645
28. Hwang, H. J., Baek, Y. M., Kim, S. W., Kumar, G. S., Cho, E. J., Oh, J. Y., and Yun, J. W. (2007) Differential expression of kidney proteins in streptozotocin-induced diabetic rats in response to hypoglycemic fungal polysaccharides. J. Microbiol. Biotechnol. 17, 2005-2017
29. Out, H. H., Can, H., Spentzos, D., Nelson, R. G., Hanson, R. L., Looker, H. C., Knowler, W. C., Monroy, M., Libermann, T. A., Karumanchi, S. A., and Thadhani, R. (2007) Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care 30, 638-643 (Pubitemid 46354346)
30. Tilton, R. G., Haidacher, S. J., Lejeune, W. S., Zhang, X., Zhao, Y., Kurosky, A., Brasier, A. R., and Denner, L. (2007) Diabetes-induced changes in the renal cortical proteome assessed with two-dimensional gel electrophoresis and mass spectrometry. Proteomics 7, 1729-1742 (Pubitemid 46841832)
31. Fliser, D., Novak, J., Thongboonkerd, V., Argilés, A., Jankowski, V., Girolami, M. A., Jankowski, J., and Mischak, H. (2007) Advances in urinary proteome analysis and biomarker discovery. J. Am. Soc. Nephrol. 18, 1057-1071
32. Jantos-Siwy, J., Schiffer, E., Brand, K., Schumann, G., Rossing, K., Delles, C., Mischak, H., and Metzger, J. (2009) Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J. Proteome Res. 8, 268-281
33. Decramer, S., Gonzalez de Peredo, A., Breuil, B., Mischak, H., Monsarrat, B., Bascands, J. L., and Schanstra, J. P. (2008) Urine in clinical proteomics. Mol. Cell. Proteomics 7, 1850-1862
34. Bogdanov, B., and Smith, R. D. (2005) Proteomics by FTICR mass spectrometry: top down and bottom up. Mass Spectrom. Rev. 24, 168-200
35. Hu, S., Loo, J. A., and Wong, D. T. (2006) Human body fluid proteome analysis. Proteomics 6, 6326-6353 (Pubitemid 44935518)
36. Meyer, H. E., and Stuhler, K. (2007) High-performance proteomics as a tool in biomarker discovery. Proteomics, 7, Suppl. 1, 18-26 (Pubitemid 351547766)
37. Tao, W. A., and Aebersold, R. (2003) Advances in quantitative proteomics via stable isotope tagging and mass spectrometry. Curr. Opin. Biotechnol. 14, 110-118
38. Chelius, D., and Bondarenko, P. V. (2002) Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J. Proteome Res. 1, 317-323 (Pubitemid 36395872)
39. Wang, W., Zhou, H., Lin, H., Roy, S., Shaler, T. A., Hill, L. R., Norton, S., Kumar, P., Anderte, M., and Becker, C. H. (2003) Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal. Chem. 75, 4818-4826
40. Steffes, M. W., and Mauer, S. M. (1984) Diabetic glomerulopathy in man and experimental animal models. Int. Rev. Exp. Pathol. 26, 147-175
41. Wang, P., Tang, H., Zhang, H., Whiteaker, J., Paulovich, A. G., and McIntosh, M. (2006) Normalization regarding non-random missing values in high-throughput mass spectrometry data. Pac. Symp. Biocomput. 315-326
42. Workman, C., Jensen, L. J., Jarmer, H., Berka, R., Gautier, L., Nielser, H. B., Saxild, H. H., Nielsen, C., Brunak, S., and Knudsen, S. (2002) A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol. 3(9):research0048
43. Hotelling, H. (1933) Analysis of a complex of statistical variables into principal components. J. Educ. Psychol. 24, 417-441
44. Efron, B. (2003) Robbins, empirical Bayes and microarrays. Ann. Stat. 31, 366-378
45. Efron, B., Tibshirani, R., Storey, J. D., and Tusher, V. (2001) Empirical Bayes analysis of a microarray experiment. J. Amer. Stat. Assoc. 96, 1151-1160
46. Lönnstedt, I., and Speed, T. P. (2002) Replicated microarray data. Stat. Sin. 12, 31-46
47. Newton, M. A., Kendziorski, C. M., Richmond, C. S., Blattner, F. R., and Tsui, K. W. (2001) On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data. J. Comput. Biol. 8, 37-52
48. Smyth, G. K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:Article3
49. Ge, Y., Dudoit, S., and Speed, T. P. (2003) Resampling-based multiple testing for microarray data analysis. Test 12, 1-77 (Pubitemid 36964087)
50. Tusher, V. G., Tibshirani, R., and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98, 5116-5121
51. Kendziorski, C. M., Newton, M. A., Lan, H., and Gould, M. N. (2003) On parametric empirical Bayes methods for comparing multiple groups using replicated gene expression profiles. Stat. Med. 22, 3899-3914
52. Newton, M. A., Noueiry, A., Sarkar, D., and Ahlquist, P. (2004) Detecting differential gene expression with a semiparametric hierarchical mixture method. Biostatistics 5, 155-176 (Pubitemid 41180221)
53. Dabney, A., and Storey, J. D. (2003) Qvalue R package: Q-value estimation for false discovery rate control. Comprehensive R Archive Network
54. Cui, X., Kerr, M. K., and Churchill, G. A. (2003) Transformations for cDNA microarray data. Stat. Appl. Genet. Mol. Biol. 2:Article4
55. Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B 57, 479-498
56. Storey, J. D. (2002) A direct approach to false discovery rates. J. R. Stat. Soc. 64, 479-498
57. Storey, J. D. (2003) The positive false discovery rate: A Bayesian interpretation and the q-value. Ann. Stat. 31, 2013-2035
58. Storey, J. D., Taylor, J. E., and Siegmund, D. (2003) Strong control, conservative point estimation, and simultaneous conservative consistency of the false discovery rates: A unified approach. J. R. Stat. Soc. 66, 187-205
59. Huber, W., von Heydebreck, A., Sultmann, H., Poustka, A., and Vingron, M. (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18, Suppl. 1, S96-S104
60. Yang, Y. H., Dudoit, S., Luu, P., Lin, D. M., Peng, V., Ngai, J., and Speed, T. P. (2002) Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30(4):e15
61. Bolstad, B. M., Irizarry, R. A., Astrand, M., and Speed, T. P. (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193 (Pubitemid 36181903)
62. Deleted in proof
63. Chow, F. Y., Nikolic-Paterson, D. J., Atkins, R. C., and Tesch, G. H. (2004) Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol. Dial. Transplant. 19, 2987-2996
64. Tesch, G. H., and Nikolic-Paterson, D. J. (2006) Recent insights into experimental mouse models of diabetic nephropathy. Nephron Exp. Nephrol. 104, e57-62
65. O'Brien, R. M., and Granner, D. K. (1996) Regulation of gene expression by insulin. Physiol. Rev. 76, 1109-1161
66. Cavaggioni, A., and Mucignat-Caretta, C. (2000) Major urinary proteins, alpha(2U)-globulins and aphrodisin. Biochim. Biophys. Acta 1482, 218-228
67. Roy, A. K., Chatterjee, B., Prasad, M. S., and Unakar, N. J. (1980) Role of insulin in the regulation of the hepatic messenger RNA for alpha 2u-globulin in diabetic rats. J. Biol. Chem. 255, 11614-11618
68. Roy, A. K., and Neuhaus, O. W. (1966) Proof of the hepatic synthesis of a sex-dependent protein in the rat. Biochim. Biophys. Acta 127, 82-87
69. Mira, E., and Castaño, J. G. (1989) Insulin short-term control of rat liver alpha 2-microglobulin gene transcription. J. Biol. Chem. 264, 18209-18212
70. Mason, R. M., and Wahab, N. A. (2003) Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol. 14, 1358-1373
71. Koya, D., Haneda, M., Nakagawa, H, Isshiki, K., Sato, H., Maeda, S., Sugimoto, T., Yasuda, H., Kashiwagi, A., Ways, D. K., King, G. L., and Kikkawa, R. (2000) Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J. 14, 439-447 (Pubitemid 30143162)
72. Park, I. S., Kiyomoto, H., Abboud, S. L., and Abboud, H. E. (1997) Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46, 473-480 (Pubitemid 27090278)
73. Ziyadeh, F. N., Sharma, K., Ericksen, M., and Wolf, G. (1994) Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J. Clin. Investig. 93, 536-542
74. Kreisberg, J. I., and Ayo, S. H. (1993) The glomerular mesangium in diabetes mellitus. Kidney Int. 43, 109-113
75. Kim, S. W., Hwang, H. J., Kim, H. M., Lee, M. C., Shik Lee, M., Choi, J. W., and Yun, J. W. (2006) Effect of fungal polysaccharides on the modulation of plasma proteins in streptozotocin-induced diabetic rats. Proteomics 6, 5291-5302 (Pubitemid 44547167)
76. Groop, L., Mäkipernaa, A., Stenman, S., DeFronzo, R. A., and Teppo, A. M. (1990) Urinary excretion of kappa light chains in patients with diabetes mellitus. Kidney Int. 37, 1120-1125 (Pubitemid 20106674)
77. Ronco, P. M., Alyanakian, M. A., Mougenot, B., and Aucouturier, P. (2001) Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level. J. Am. Soc. Nephrol. 12, 1558-1565
78. Ronco, P., Plaisier, E., Mougenot, B., and Aucouturier, P. (2006) Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy. Clin. J. Am. Soc. Nephrol. 1, 1342-1350